Last reviewed · How we verify
NCT02567045
Uptake to Colorectal Cancer Screening in Familial-risk Population
NA trial testing annual FIT and colonoscopy in case of a positive test in Colorectal Cancer in 260 participants. Completed in 24 March 2020.
31 December 2019
Quick facts
| Lead sponsor | Hospital Universitario de Canarias |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 260 |
| Start date | 25 February 2016 |
| Primary completion | 31 December 2019 |
| Estimated completion | 24 March 2020 |
| Sites | 7 locations across Spain |
Drugs / interventions tested
- annual FIT and colonoscopy in case of a positive test
- colonoscopy with sedation
Conditions studied
- Colorectal Cancer — all drugs for Colorectal Cancer →
- Screening Uptake of Colonoscopy and FIT — all drugs for Screening Uptake of Colonoscopy and FIT →
Sponsor
Hospital Universitario de Canarias
Who can join
Adults 18 to 40, any sex, with Colorectal Cancer or Screening Uptake of Colonoscopy and FIT. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a multicenter, controlled, randomized phase III study to compare participation rate with two screening rounds of fecal occult blood test (FIT) versus one-time screening colonoscopy in first degree relatives (FDR) of patients diagnosed of colorectal cancer (CRC). The hypothesis of the study is that annual FIT uptake and colonoscopy when a positive test is higher than that of straightforward colonoscopy. Assuming an uptake of 0.50 for colonoscopy and 0.60 for FIT, a Type I error (alpha) of 5% and a power of 90%, 538 FDRs will be necessary to include in each group.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).
González-López N, Quintero E, Gimeno-Garcia AZ, Bujanda L, et al · · 2023 · cited 6× · PMID 37874831 · DOI 10.1371/journal.pmed.1004298
Verify or expand the search:
- PubMed search for NCT02567045
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colorectal Cancer
Currently open trials in the same condition.
- NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
- NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
- NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
- NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
- NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting
Other Hospital Universitario de Canarias trials
Trials by the same sponsor.
- NCT05956119 — Effectiveness of Dry Needling for Improving Gait in the Patient With Multiple Sclerosis · NA · completed
- NCT05141773 — Artificial Intelligence Aid Systems and Endocuff in Colorectal Adenoma Detection · NA · completed
- NCT05553977 — Artificial Intelligence and Bowel Cleansing Quality · unknown
- NCT04945044 — Artificial Intelligence Aid Systems in Colorectal Adenoma Detection · NA · completed
- NCT05053984 — Ultrasound-Guided Percutaneous Neuromodulation in Spasticity · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02567045 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitario de Canarias
- Last refreshed: 10 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02567045.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing